All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

97

Reset

97 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Dual-target CAR-NK cellsEB-DT-CAR-NK, Essen Biotech Dual-Target CAR-NKPhase 25 trials

    Beijing Biotech · HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer (Locally Advanced or Metastatic)

  • ABSK043Phase 24 trials

    Abbisko Therapeutics Co, Ltd · Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive, HER2-Gastric/Gastroesophageal Junction Cancer

  • IL-2MDNA11, Interleukin-2 -albuminPhase 24 trials

    Grit Biotechnology · Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma

  • BalstilimabAGEN2034Phase 23 trials

    ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer

  • BT5528nuzefatide pevedotinPhase 23 trials

    BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer

  • JPI-547Phase 23 trials

    Onconic Therapeutics Inc. · Pancreatic Ductal Adenocarcinoma, Gastric Cancer (GC), Ovarian Cancer

  • PD-L1 t-haNKPhase 23 trials

    ImmunityBio, Inc. · Pancreatic Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

  • SSGJ-706Phase 23 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Non Small Cell Lung Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC)

  • ABSK061Phase 22 trials

    Abbisko Therapeutics Co, Ltd · HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer

  • and oxaliplatinPhase 22 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma

  • Carboplatin AUC-5Phase 22 trials

    Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer

  • DenikitugGS-1811, DENPhase 22 trials

    Gilead Sciences · Advanced Microsatellite Stable Colorectal Cancer, HER2-negative, Gastroesophageal Junction

  • ImzokitugBMS-986340Phase 22 trials

    Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer

  • OsrhCTRecombinant Human Chymotrypsin 4000UPhase 22 trials

    Healthgen Biotechnology Corp. · Gastric Mucosal Lesion

  • rhuGM-CSFGranulocyte-Macrophage Colony-Stimulating FactorPhase 22 trials

    Aston Sci. Inc. · Gastric Cancer, Advanced Ovarian Cancer

  • S095029Phase 22 trials

    Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC), MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer

  • SAR445877Phase 22 trials

    Sanofi · Solid Tumor, Gastric Cancer, Oesophageal Carcinoma

  • TCC1727Phase 22 trials

    Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)

  • TRK-950Phase 22 trials

    Toray Industries, Inc · Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

  • TST001Phase 22 trials

    Transcenta Therapeutics (Hangzhou) Co., Ltd. · Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer

  • XNW27011ASP546CPhase 22 trials

    Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic

  • APL-101Phase 21 trial

    Apollomics Inc. · Solid Tumors, Advanced Cancer, Renal Cancer

  • AST-301pNGVL3-hICDPhase 21 trial

    Aston Sci. Inc. · Gastric Cancer

  • AZD4360Phase 21 trial

    AstraZeneca · Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer

  • AZD5863Phase 21 trial

    AstraZeneca · Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma

  • AZD6750Phase 21 trial

    AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)

  • AZD7789Phase 21 trial

    AstraZeneca · Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer

  • BDC-4182Phase 21 trial

    Bolt Biotherapeutics, Inc. · Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma

  • BHB810Phase 21 trial

    BigHat Biosciences, Inc. · Gastric Cancer, Gastric Adenocarcinoma, Gastric (Stomach) Cancer

  • CBX-12Phase 21 trial

    Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma

  • CR-002Phase 21 trial

    Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)

  • CR6086vorbipiprantPhase 21 trial

    Rottapharm Biotech · Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer

  • CT041Phase 21 trial

    CARsgen Therapeutics Co., Ltd. · Gastric Cancer, Pancreatic Cancer

  • EIK1005Phase 21 trial

    Eikon Therapeutics · Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors, MSI-H/dMMR Gastric Cancer

  • IDX-1197Phase 21 trial

    Idience Co., Ltd. · Gastric Cancer

  • LUM015Phase 21 trial

    Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer

  • MDSY-1240Phase 21 trial

    Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic

  • MDX2001Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer

  • MT-4561Phase 21 trial

    Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer

  • NDI-101150Phase 21 trial

    Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

  • NEO212POH-TMZPhase 21 trial

    Neonc Technologies, Inc. · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult

  • Q702Phase 21 trial

    Qurient Co., Ltd. · Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer

  • SL-28Phase 21 trial

    Second Life Therapeutics · Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic

  • SNS-101anti-VISTAPhase 21 trial

    Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer

  • SYS6062Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC)

  • TH9619Phase 21 trial

    One-carbon Therapeutics AB · Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck

  • XYA02Phase 21 trial

    XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer

NewerPage 2 of 2

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.